We are live on
!
Find out more
BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$272M
1-Year Est. Return
30.95%
This Fund
S&P 500
This Quarter
Est. Return
-0.29%
1 Year Est. Return
+30.95%
3 Year Est. Return
+75.66%
5 Year Est. Return
+99.24%
10 Year Est. Return
+591.34%
AUM
$127M
AUM Growth
-$4.96M
(-3.8%)
Cap. Flow
-$4.11M
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
77.16%
Holding
60
New
1
Increased
9
Reduced
22
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$219K |
| 2 |
Tompkins Financial
TMP
|
+$111K |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
+$97.7K |
| 4 |
United Parcel Service
UPS
|
+$40.7K |
| 5 |
Verizon
VZ
|
+$39.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$940K |
| 2 |
CELG
Celgene Corp
CELG
|
+$799K |
| 3 |
Johnson & Johnson
JNJ
|
+$289K |
| 4 |
T. Rowe Price
TROW
|
+$234K |
| 5 |
Pfizer
PFE
|
+$208K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.01% |
| 2 | Technology | 26.21% |
| 3 | Communication Services | 5.9% |
| 4 | Financials | 3.54% |
| 5 | Consumer Discretionary | 2.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $53.3M | 41.93% |
460,557
-6,992
| -1% | -$799K |
|
2
Adobe
ADBE
$84.3B
| $8.97M | 7.06% |
110,730
-350
| -0.3% | -$27.3K |
|
3
Idexx Laboratories
IDXX
$42.5B
| $6.74M | 5.3% |
105,000
-2,980
| -3% | -$206K |
|
4
Microsoft
MSFT
$2.83T
| $5.79M | 4.56% |
131,222
-2,720
| -2% | -$124K |
|
5
Alphabet (Google) Class C
GOOG
$3.88T
| $5.6M | 4.4% |
211,280
-1,743
| -0.8% | -$46.7K |
|
6
Apple
AAPL
$4.72T
| $5.55M | 4.36% |
176,896
+812
| +0.5% | +$26K |
|
7
Paychex
PAYX
$39.4B
| $4.13M | 3.24% |
87,995
-2,800
| -3% | -$137K |
|
8
Cisco
CSCO
$444B
| $2.95M | 2.32% |
107,438
-1,684
| -2% | -$48.3K |
|
9
Booking.com
BKNG
$134B
| $2.59M | 2.04% |
56,250
| – | – |
|
10
Intuitive Surgical
ISRG
$119B
| $2.48M | 1.95% |
45,999
| – | – |
|
11
Qualcomm
QCOM
$180B
| $2.09M | 1.64% |
33,378
-400
| -1% | -$27.3K |
|
|
EMC
12
DELISTED
EMC CORPORATION
EMC
| $1.92M | 1.51% |
72,732
-1,000
| -1% | -$26.7K |
|
|
13
T. Rowe Price
TROW
$24.6B
| $1.51M | 1.19% |
19,400
-2,900
| -13% | -$234K |
|
14
AT&T
T
$160B
| $1.39M | 1.09% |
51,860
+397
| +0.8% | +$10.3K |
|
|
15
Johnson & Johnson
JNJ
$624B
| $1.39M | 1.09% |
14,230
-2,885
| -17% | -$289K |
|
|
POT
16
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.33M | 1.04% |
42,895
+3,050
| +8% | +$97.7K |
|
17
GE Aerospace
GE
$362B
| $1.24M | 0.98% |
9,768
-1,242
| -11% | -$161K |
|
18
ExxonMobil
XOM
$650B
| $1.02M | 0.8% |
12,267
-12
| -0.1% | -$1.03K |
|
|
19
Pfizer
PFE
$143B
| $962K | 0.76% |
30,236
-6,377
| -17% | -$208K |
|
|
20
Tompkins Financial
TMP
$1.33B
| $956K | 0.75% |
17,800
+2,100
| +13% | +$111K |
|
21
Quanta Services
PWR
$98.1B
| $931K | 0.73% |
32,310
-700
| -2% | -$20.5K |
|
|
SE
22
DELISTED
Spectra Energy Corp Wi
SE
| $927K | 0.73% |
28,450
+800
| +3% | +$28.5K |
|
|
23
United Parcel Service
UPS
$97B
| $880K | 0.69% |
9,085
+410
| +5% | +$40.7K |
|
24
Pacific Biosciences
PACB
$435M
| $879K | 0.69% |
152,575
+5,000
| +3% | +$28.9K |
|
|
MON
25
DELISTED
Monsanto Co
MON
| $845K | 0.66% |
7,925
| – | – |
|
Similar funds
SC
SC
RAM
AGP
SFPG
TP
S
SS
Bourne Lent Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Bourne Lent Asset Management held 60 positions worth $127M, down 3.8% from $132M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Bourne Lent Asset Management withdrew a net $4.11M in Q2 2015, closing 9 positions and reducing 22 holdings. Its most notable exit was AbbVie, an estimated $940K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 55% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Bourne Lent Asset Management opened a new position in Gilead Sciences worth $234K.
- Bourne Lent Asset Management's largest Q2 2015 buy was Gilead Sciences: 2,000 shares worth $234K.
- Bourne Lent Asset Management added most to Tompkins Financial in Q2 2015, an estimated $111K increase.
- Bourne Lent Asset Management's biggest Q2 2015 reduction was Celgene Corp, cutting an estimated $799K.
- Bourne Lent Asset Management fully exited AbbVie in Q2 2015, selling an estimated $940K.
- Bourne Lent Asset Management's ten largest holdings make up 77% of its $127M portfolio in Q2 2015.
- Bourne Lent Asset Management opened 1 new position and closed 9 in Q2 2015.
- Bourne Lent Asset Management's portfolio value fell 3.8% quarter-over-quarter to $127M.
Based on Bourne Lent Asset Management's 13F filing for Q2 2015, filed 28 Jul 2015.